What is the plasma half-life of Dipyridamole after infusion?

The plasma half-life of Dipyridamole after infusion is typically approximately 30 to 40 minutes. This pharmacokinetic property is essential for understanding how the drug behaves in the body following administration.

Dipyridamole acts as a vasodilator and is often used in conjunction with imaging agents in cardiovascular studies, including PET scans. The half-life indicates the time required for the concentration of the drug in the plasma to reduce by half, which can significantly impact the timing of imaging and the interpretation of results.

The 30 to 40-minute range allows for effective pharmacological management as it indicates the duration of the drug's peak effect while also suggesting a reasonable timeframe for monitoring patients who have received it in a clinical setting, especially during imaging procedures.